To maximize effect and capitalize on existing/future inventory...proper dosing seems to be the magic bullet...but with variance in patient condition... that might be hard to load.... in a case-by-case situation. The importance of reduction in cytokine load has to be number one... and underlying comorbidities number two. NOT a doctor...but seems logical.